Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Stiles, P. G.
* Articles by Williams, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Stiles, P. G.
* Articles by Williams, R.
Related Collections
* Informed Consent
* Depression
* Schizophrenia Spectrum Disorders
Psychiatr Serv 52:780-785, June 2001
© 2001 American Psychiatric Association


Other Articles

Improving Understanding of Research Consent Disclosures Among Persons With Mental Illness

Paul G. Stiles, J.D., Ph.D., Norman G. Poythress, Ph.D., Alicia Hall, M.A., Diana Falkenbach, M.A. and Robyn Williams, M.A.

OBJECTIVE: The objective of this study was to evaluate alternative procedures for improving the understanding of research consent disclosures by persons who have mental illness. METHODS: Three groups participated in the study: persons with schizophrenia (N=79), persons with depression (N=82), and a healthy control group (N=80). The participants were guided through an informed consent process in which two factors were manipulated. One was the structure of the disclosure form; either a typical disclosure form involving standard dense text was used, or a graphically enhanced form was used. The other was the interpersonal process: the presence or absence of a third-party facilitator, with iterative feedback given to participants for whom a facilitator was not present. Participants' understanding of the disclosure was assessed with the use of recall tests that involved paraphrasing and recognition tests that involved multiple choice. RESULTS: The mean understanding scores did not differ significantly between the depression and control groups, and the mean scores of the schizophrenia group were significantly lower than those of the other two groups. Neither the graphically enhanced consent disclosure form nor the presence of a third-party facilitator was associated with improved understanding. The use of iterative feedback was associated with improvement in comprehension scores in all groups. CONCLUSIONS: The use of a feedback procedure in the consent disclosure process during the recruitment of persons who are mentally ill may be a valuable safeguard for ensuring adequate understanding and appropriate participation in research.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
P. T. Yanos, B. S. Stanley, and C. S. Greene
Research Risk for Persons With Psychiatric Disorders: A Decisional Framework to Meet the Ethical Challenge
Psychiatr Serv, March 1, 2009; 60(3): 374 - 383.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
P. Fortun, J. West, L. Chalkley, A. Shonde, and C. Hawkey
Recall of informed consent information by healthy volunteers in clinical trials
QJM, August 1, 2008; 101(8): 625 - 629.
[Abstract] [Full Text] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
M. L. Spath
Continued Controversies: Issues in Mental Health Research and Implications for Nursing
Journal of the American Psychiatric Nurses Association, September 1, 2007; 13(4): 221 - 229.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
L. W. Roberts, T. D. Warner, K. G. Hammond, and L. B. Dunn
Assessments by Patients With Schizophrenia and Psychiatrists of Relative Risk of Research Procedures
Psychiatr Serv, November 1, 2006; 57(11): 1629 - 1635.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. F. Schulte
Risk of Clozapine-Associated Agranulocytosis and Mandatory White Blood Cell Monitoring
Ann. Pharmacother., April 1, 2006; 40(4): 683 - 688.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
L. B Dunn, P. J Candilis, and L. W. Roberts
Emerging Empirical Evidence on the Ethics of Schizophrenia Research
Schizophr Bull, January 1, 2006; 32(1): 47 - 68.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
L. B Dunn, B. W Palmer, and M. Keehan
Understanding of Placebo Controls Among Older People With Schizophrenia
Schizophr Bull, January 1, 2006; 32(1): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Flory and E. Emanuel
Interventions to Improve Research Participants' Understanding in Informed Consent for Research: A Systematic Review
JAMA, October 6, 2004; 292(13): 1593 - 1601.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. D. Buckles, K. K. Powlishta, J. L. Palmer, M. Coats, T. Hosto, A. Buckley, and J. C. Morris
Understanding of informed consent by demented individuals
Neurology, December 23, 2003; 61(12): 1662 - 1666.
[Abstract] [Full Text] [PDF]


Home page
J Law Med EthicsHome page
N. G. Poythress
Obtaining Informed Consent for Research: A Model for Use with Participants Who Are Mentally Ill
J. Law Med. Ethics, September 1, 2002; 30(3): 367 - 374.
[PDF]


Home page
JWatch PsychiatryHome page
Improving Informed Consent for Mentally Ill Patients
Journal Watch Psychiatry, July 11, 2001; 2001(711): 5 - 5.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org